Westfield Capital Management CO LP Pacira Bio Sciences, Inc. Transaction History

Westfield Capital Management CO LP

$21.6 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$38.19 - $57.45 $18.7 Million - $28.2 Million	-490,737 Reduced 94.25%	29,960 $1.16 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $247,950 - $284,968	-4,839 Reduced 0.92%	520,697 $27.7 Million
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $5.51 Million - $8.74 Million	107,034 Added 25.58%	525,536 $30.6 Million
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $40.5 Million - $51.6 Million	-674,980 Reduced 61.73%	418,502 $31.9 Million
Q4 2021 Feb 10, 2022	SELL	$47.97 - $62.21 $1.58 Million - $2.04 Million	-32,837 Reduced 2.92%	1,093,482 $65.8 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $5.23 Million - $5.86 Million	95,674 Added 9.28%	1,126,319 $63.1 Million
Q2 2021 Aug 10, 2021	BUY	$59.18 - $69.99 $29.8 Million - $35.2 Million	503,548 Added 95.53%	1,030,645 $62.5 Million
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $23.7 Million - $31.5 Million	-399,891 Reduced 43.14%	527,097 $36.9 Million
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $717,330 - $941,753	14,213 Added 1.56%	926,988 $55.5 Million
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $23.3 Million - $28.3 Million	-448,467 Reduced 32.95%	912,775 $54.9 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $11.1 Million - $18.9 Million	361,072 Added 36.1%	1,361,242 $71.4 Million
Q1 2020 May 14, 2020	BUY	$28.4 - $50.7 $7.35 Million - $13.1 Million	258,781 Added 34.9%	1,000,170 $33.5 Million
Q4 2019 Feb 13, 2020	BUY	$36.31 - $46.83 $8.22 Million - $10.6 Million	226,460 Added 43.98%	741,389 $33.6 Million
Q3 2019 Nov 08, 2019	BUY	$35.66 - $44.99 $18.4 Million - $23.2 Million	514,929 New	514,929 $19.6 Million
Q2 2018 Aug 13, 2018	SELL	$27.5 - $39.8 $22.9 Million - $33.2 Million	-834,282 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$29.98 - $46.35 $12.3 Million - $19.1 Million	-411,641 Reduced 33.04%	834,282 $26 Million
Q4 2017 Feb 13, 2018	SELL	$31.85 - $46.95 $1.27 Million - $1.87 Million	-39,927 Reduced 3.11%	1,245,923 $56.9 Million
Q3 2017 Nov 13, 2017	BUY	$35.7 - $39.5 $45.9 Million - $50.8 Million	1,285,850	1,285,850 $48.3 Million

Others Institutions Holding PCRX

# of Institutions

259

Shares Held

49.5M

Call Options Held

1.03M

Put Options Held

139K

Black Rock Inc. New York, NY

8.01M
Shares

$204 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.26M
Shares

$134 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

3.26M
Shares

$83 Million
0.15% of portfolio
D. E. Shaw & Co., Inc. New York, NY

2.26M
Shares

$57.5 Million
0.03% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.99M
Shares

$50.7 Million
0.06% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.17B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Account